Where are somatoform disorders going? An update on the DSM-V

Click to increase image sizeClick to decrease image size

Financial & competing interests disclosure

MR Schoenberg has received honorarium from HCR ManorCare, Taylor and Francis, and the Scientific Peer Advisory and Review Services Division of the American Institute of Biological Sciences. SR Benbadis has served as a consultant for, has received research support from, or is on the speakers’ bureau for Cyberonics, GlaxoSmithKline, Lundbeck, Sunovion, UCB Pharma and Vertex Pharmaceuticals. MR Schoenberg has received royalties from Springer. SR Benbadis has received royalties from Emedicine-WebMD-Medscape, UpToDate and Demos. MR Schoenberg serves as Associate Editor for The Clinical Neuropsychologist, Taylor and Francis, and on the Editorial Boards of Archives of Clinical Neuropsychology, Current Gerontology and Geriatrics Research, and Psychiatry Journal. SR Benbadis serves as Editor-in-Chief (Neurology) for WebMD-Medscape, and is on the Editorial Boards of Epilepsy and Behavior, Epileptic Disorders and European Neurology. MR Schoenberg serves on the Board of Directors for the American Board of Clinical Neuropsychology, as a grant reviewer for the Epilepsy Foundation and the Scientific Peer Advisory and Review Services Division of the American Institute of Biological Sciences, and on the Guideline Committee and the Practice Management Committees, Council on Clinical Activities, American Epilepsy Society. MR Schoenberg also receives a salary from the USA Department of Defence, University of South Florida and the Florida Department of Elderly Affairs. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.